One argument, built one piece at a time.
Everything here is a single idea, built out over time and fit together on purpose. It is written for the leader of a small, clinical-stage biotech, and the person they task with AI, who needs the whole picture without a spare month to assemble it. This is the map of the framework, and the order it makes sense to learn it in. Read it top to bottom and you come away with the argument, the language, and a place to start.
Read them in the order they connect.
Each one links out. Start at the top and let it pull you through; by the end you have the whole argument and the language to use it.
- 1The argument
The Biotech of Tomorrow
You cannot build tomorrow's biotech by making yesterday's a little more efficient. The founding piece; read it first.
- 2The idea
Translational Intelligence
The idea the whole thing is named for: the capacity to keep turning new capability into durable advantage.
- 3The system
Permission, People, Programs
The operating system that builds the capacity, across three pillars that grow together.
- 4The discipline
Buy the Record. Build the Intelligence.
Buy the system of record. Build the system of intelligence. How to tell which is which, so your scarce engineering lands only on what is yours.
- 5The role
The AI Product Partner
The person who makes it real: one part enablement, one part product.
- 6The destination
The AI-Native Biotech
The company you become when it all runs, designed to never stop translating.
Arrived with a specific problem? Start here.
The map above teaches the whole system in order. If you came in with one urgent question instead, jump straight to the piece that answers it.
- I run a biotech under 100 people.The Small-Team Operating Model →
- My science is outsourced to CROs.Where AI Touches a Clinical-Stage Biotech →
- I need an AI use policy.A Lightweight AI Use Policy →
- I have to show my board progress.The PPP Scorecard →
- We have licenses but weak adoption.People First, or Not at All →
- We are running too many pilots.There Are Only Five Moves →
- Build it, or buy it?The Build-vs-Buy Framework →
- I need someone to own this.The AI Product Partner →
- AI is touching a validated workflow.The validated-workflow answer →
The library grows every week.
New Insights deepen these arguments every week: the Issues take one argument apart, the FAQs answer what leaders ask most. Each one names something, explains something, or hands you something you can use. When you move from the argument to execution, the Scope Ladder helps you name how big a change you are attempting, from an afternoon to a restructure.
Want them in the tool you already think in? Here is how to read them in your chatbot. Subscribe, and I will send each piece as it goes out. To see the whole territory, what is covered and what is coming, here is the coverage map.